Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...
The XEC Covid variant is a recombinant of Omicron and is proving to be more infectious. It has already driven a surge in ...
The authors note that health care providers in the U.S. also face major challenges in achieving high vaccination rates against COVID-19, respiratory syncytial virus (RSV) and influenza, which confers ...